⌘K

Login Start Free

Home/Filings/4/0001628280-21-012170

4//SEC Filing

Armitage James O 4

Accession 0001628280-21-012170

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:11 PM ET

Size

5.3 KB

Accession

0001628280-21-012170

Insider Transaction Report

Form 4

Period: 2021-06-10

Cardiff Oncology, Inc.CRDF

Armitage James O

Director

Transactions

Award
Stock Options
2021-06-10+22,000→ 62,774 total
Exercise: $7.98From: 2022-06-10Exp: 2031-06-10→ Common Stock (22,000 underlying)

Documents

1 file

4
wf-form4_162370144457487.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001370087

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:11 PM ET
Size: 5.3 KB

View on SEC.gov